Loss of primary cilia promotes EphA2 ‐mediated endothelial‐to‐mesenchymal transition in the ovarian tumor microenvironment
Molecular Oncology · 2025
DOI: 10.1002/1878-0261.70057 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Oncology, 2025. Verfasst von Jin Gu Cho und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biological Sciences, Sookmyung Women's University, Seoul, Korea. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Tumor Microenvironment, Cilia, Receptor, EphA2. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Health Industry Development Institute, Korea Basic Science Institute, Ministry of Science and ICT, South Korea.
Abstract (Originalsprache)
Endothelial‐to‐mesenchymal transition (EndMT) is closely associated with tumor progression. Endothelial cells (ECs) in the tumor microenvironment (TME) use EndMT programs to facilitate tumor progression; however, the underlying mechanisms in ovarian cancer are poorly understood. Here, we describe the involvement of primary cilia in EndMT of the ovarian TME. We showed that ECs from human ovarian tumors displayed robust EndMT and impaired cilia formation, as was also observed in ECs in response to ovarian cancer cell culture‐conditioned media (OV‐CM). Notably, ECs lacking primary cilia exhibited increased OV‐CM‐induced EndMT. Vascular abnormalities, such as enhanced cell migration and vessel permeability, were observed in vitro . Furthermore, in vivo experiments using endothelial‐specific kinesin family member 3A ( Kif3a )‐knockout mice showed enhanced EndMT in the ovarian TME. Mechanistically, we identified ephrin type‐A receptor 2 (EphA2) as a key regulator of EndMT. Upon OV‐CM treatment, EphA2 expression increased, and depletion of EphA2 in ECs decreased OV‐CM‐induced EndMT and vascular abnormalities. These results highlight that the loss of primary cilia and the consequent EphA2 activation are key mechanisms by which EndMT programs induce the acquisition of cancer‐associated fibroblast‐like cells in the ovarian TME, thereby promoting ovarian cancer progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Biological Sciences, Sookmyung Women's University, Seoul, Korea.
- Research Institute for Women's Health, Sookmyung Women's University, Seoul, Korea.
- Department of Obstetrics and Gynecology, Kyung Hee University College of Medicine, Kyung Hee University Medical Center, Seoul, Korea.
- Department of Obstetrics and Gynecology, Pusan National University School of Medicine, Biomedical Research Institute, Pusan National University Hospital, Korea.
ORCID-Profile: Yubin Hah, Jong Hoon Park, Byung Su Kwon, Young Yang, Jongmin Kim
Förderung
- Korea Health Industry Development Institute
- Korea Basic Science Institute
- Ministry of Science and ICT, South Korea
- National Research Foundation of Korea
Zitieren
APA
Cho, J. G., Hah, Y., Yun, E., Ka, H. I., Lee, A., Han, S., Lee, D., Kim, S. W., Park, J. H., Kwon, B. S., Yang, Y., & Kim, J. (2025). Loss of primary cilia promotes EphA2 ‐mediated endothelial‐to‐mesenchymal transition in the ovarian tumor microenvironment. Molecular Oncology. https://doi.org/10.1002/1878-0261.70057
Vancouver
Cho JG, Hah Y, Yun E, Ka HI, Lee A, Han S, et al. Loss of primary cilia promotes EphA2 ‐mediated endothelial‐to‐mesenchymal transition in the ovarian tumor microenvironment. Molecular Oncology. 2025. doi:10.1002/1878-0261.70057
BibTeX
@article{Cho2025,
author = {Cho, Jin Gu and Hah, Yubin and Yun, Eunsik and Ka, Hye In and Lee, Aram and Han, Sora and Lee, Dawn and Kim, Sung Wook and Park, Jong Hoon and Kwon, Byung Su and Yang, Young and Kim, Jongmin},
title = {Loss of primary cilia promotes EphA2 ‐mediated endothelial‐to‐mesenchymal transition in the ovarian tumor microenvironment},
journal = {Molecular Oncology},
year = {2025},
doi = {10.1002/1878-0261.70057}
}
EUVIMED